Metformin: Difference between revisions
(Text replacement - "N/V" to "nausea and vomiting") |
Neil.m.young (talk | contribs) (Text replacement - "0 mg" to "0mg") |
||
| Line 11: | Line 11: | ||
*Hold 48 hours for iodinated contrast | *Hold 48 hours for iodinated contrast | ||
;'''Immediate Release''' | ;'''Immediate Release''' | ||
*850- | *850-1000mg PO bid | ||
*Start | *Start 500mg bid or 850mg qd | ||
*Increase | *Increase 500mg qwk or 850mg q2wk | ||
*Max | *Max 2550mg/day | ||
;'''Extended Release''' | ;'''Extended Release''' | ||
*1000- | *1000-2000mg PO qd | ||
*Start | *Start 500mg qd | ||
**Increase | **Increase 500mg qwk | ||
*Alt dosing; | *Alt dosing; 1000mg bid | ||
**Add | **Add 500mg immediate release for inadequate response | ||
*Do not crush or chew | *Do not crush or chew | ||
| Line 27: | Line 27: | ||
*Hold for iodinated contrast | *Hold for iodinated contrast | ||
;'''Immediate Release''' | ;'''Immediate Release''' | ||
* | *500mg tid | ||
*Alt dosing; 850- | *Alt dosing; 850-1000mg bid | ||
*Increase as needed | *Increase as needed | ||
*Max | *Max 2550mg/day | ||
;'''Extended Release''' | ;'''Extended Release''' | ||
*1500- | *1500-2000mg qd | ||
*Do not crush or chew | *Do not crush or chew | ||
*Max | *Max 2000mg/day | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
| Line 41: | Line 41: | ||
*Children aged 10-18 years of age | *Children aged 10-18 years of age | ||
===Diabetes Mellitus type 2=== | ===Diabetes Mellitus type 2=== | ||
*500- | *500-1000mg bid | ||
*Start | *Start 500mg qd | ||
*Increase | *Increase 500mg/day every 1-2 weeks | ||
*Max | *Max 2000mg/day | ||
==Special Populations== | ==Special Populations== | ||
Revision as of 16:32, 19 July 2016
Administration
- Type: Diabetes medication
- Dosage Forms: 500, 850, 1000; ER 500, 750, 1000
- Routes of Administration: PO
- Common Trade Names: Fortamet, Glucophage, Glumetza, Riomet
Adult Dosing
Diabetes Mellitus type 2
- Take with meals
- Hold 48 hours for iodinated contrast
- Immediate Release
- 850-1000mg PO bid
- Start 500mg bid or 850mg qd
- Increase 500mg qwk or 850mg q2wk
- Max 2550mg/day
- Extended Release
- 1000-2000mg PO qd
- Start 500mg qd
- Increase 500mg qwk
- Alt dosing; 1000mg bid
- Add 500mg immediate release for inadequate response
- Do not crush or chew
Polycystic Ovarian Syndrome
- Take with meals
- Hold for iodinated contrast
- Immediate Release
- 500mg tid
- Alt dosing; 850-1000mg bid
- Increase as needed
- Max 2550mg/day
- Extended Release
- 1500-2000mg qd
- Do not crush or chew
- Max 2000mg/day
Pediatric Dosing
- Take with meals
- Hold for iodinated contrast
- Children aged 10-18 years of age
Diabetes Mellitus type 2
- 500-1000mg bid
- Start 500mg qd
- Increase 500mg/day every 1-2 weeks
- Max 2000mg/day
Special Populations
- Pregnancy Rating: B
- Lactation risk: Probably safe
Renal Dosing
- Adult: Contraindicated Cr>1.4 in females and Cr>1.5 in med
- Pediatric: Contraindicated Cr>1.4 in females and Cr>1.5 in med
Hepatic Dosing
- Adult: Avoid with hepatic impairment
- Pediatric: Avoid with hepatic impairment
Contraindications
- Allergy to class/drug
- Cr >1.4 female or >1.5 male
- Metabolic acidosis
- DKA
- Lactic acidosis
- Iodinated contrast
- Hypoxemia
- Dehydration
- Sepsis
- Surgery
- Hepatic impairment
- Caution
- CHF
- Elderly
- Alcohol abuse
- Hypoglycemia risk
Adverse Reactions
Serious
- Lactic acidosis
- Megaloblastic anemia
Common
- Diarrhea
- nausea and vomiting
- Flatulence
- Indigestion
- Abdominal discomfort
- Anorexia
- Headache
- Rash
- Ovulation reduction
Pharmacology
- Half-life: 6 hours in plasma and 17 hours in blood
- Metabolism: CYP450
- Excretion: Urine
Mechanism of Action
- Decreases hepatic glucose production and intestinal absorption
- Increases insulin sensitivity
Comments
See Also
References
- Epocrates
